5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: a clinical experience.
Lisa
L
Podolsky
Melissa
M
Oh
Pochi R
PR
Subbarayan
Dido
D
Francheschi
Alan
A
Livingstone
Bach
B
Ardalan
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage; D017321:Clinical Trials, Phase I as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010087:Oxides / Q000008:administration & dosage; D016896:Treatment Outcome
D001152:Arsenicals; D010087:Oxides; D002955:Leucovorin; D000077237:Arsenic Trioxide; D005472:Fluorouracil